ZI
ZIVO Bioscience, Inc.
ZIVO · OTC
$3.50 +9.37% (+$0.30)
1M -28.89%
Market Cap $12.4M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 189.62x
PEG N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
12 /100
Weak Op. margin 8,327.18%
Gross margin 32.44%
FCF margin 3,790.06%
Quality
60 /100
Average Asset turnover 0.15x
ROIC 194.30%
ROA 1,241.30%
Debt
0 /100
High Int. coverage -141.10x
Current ratio 0.10x
Debt/Assets N/A
Stability
44 /100
Moderate Profitable years 0
Beta 0.11x
EPS volatility 10.38%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ZIVO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Bernard Payne
Employees
7
Headquarters
Troy
Nadcházející události
02 PRO
Earnings
Upcoming earnings report